Elmwood Wealth Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	102,944 +20	+0%	+$280	0.44%	59
2026 Q1	$1.32M	Buy	102,924 +25,000	+32%	+$318K	0.36%	68
2025 Q4	$701K	Sell	77,924 -135	-0.2%	-$1.86K	0.22%	99
2025 Q3	$1.35M	Buy	78,059 +10,135	+15%	+$125K	0.48%	61
2025 Q2	$637K	Buy	67,924 +135	+0.2%	+$1.11K	0.25%	87
2025 Q1	$482K	Buy	67,789 +15	+0%	+$152	0.2%	97
2024 Q4	$790K	Hold	67,774	–	–	0.32%	83
2024 Q3	$1.39M	Buy	67,774 +600	+0.9%	+$13.8K	0.57%	62
2024 Q2	$1.5M	Sell	67,174 -725	-1%	-$17.3K	0.67%	57
2024 Q1	$1.87M	Sell	67,899 -10	-0%	-$278	0.8%	48
2023 Q4	$2.07M	Buy	67,909 +10	+0%	+$287	1.45%	19
2023 Q3	$2.15M	Hold	67,899	–	–	1.04%	31
2023 Q2	$2.77M	Hold	67,899	–	–	1.29%	24
2023 Q1	$2.53M	Hold	67,899	–	–	1.2%	27
2022 Q4	$2.37M	Hold	67,899	–	–	1.18%	24
2022 Q3	$3.8M	Hold	67,899	–	–	1.9%	8
2022 Q2	$3.51M	Buy	67,899 +300	+0.4%	+$15.2K	2%	11
2022 Q1	$4.91M	Buy	67,599 +425	+0.6%	+$36K	2.52%	5
2021 Q4	$7.94M	Buy	+67,174	New	+$8.42M	3.79%	2
2021 Q2	$10.9M	Hold	67,174	–	–	5.73%	1
2021 Q1	$5.39M	Buy	+67,174	New	+$4.51M	3.29%	4
2020 Q3	$1.35M	Hold	64,204	–	–	1.09%	28
2020 Q2	$1.35M	Buy	64,204 +15,066	+31%	+$256K	1.09%	28
2020 Q1	$1.04M	Sell	49,138 -15,066	-23%	-$203K	0.99%	37
2019 Q4	$942K	Sell	64,204 -65,235	-50%	-$908K	0.82%	53
2019 Q3	$1.73M	Sell	129,439 -3,705	-3%	-$59.1K	1.75%	15
2019 Q2	$2.18M	Sell	133,144 -3,705	-3%	-$58.2K	1.93%	7
2019 Q1	$2.34M	Buy	136,849 +75,227	+122%	+$1.12M	2.16%	5
2018 Q4	$841K	Sell	61,622 -3,705	-6%	-$68.9K	0.81%	45
2018 Q3	$1.87M	Buy	65,327 +4,985	+8%	+$145K	1.55%	17
2018 Q2	$1.65M	Buy	60,342 +11,204	+23%	+$271K	1.5%	19
2018 Q1	$1.04M	Buy	+49,138	New	+$1.21M	0.99%	37

Other funds holding NTLA